Ipswich Investment Management’s Barinthus Biotherapeutics BRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-17,575
| Closed | -$21.2K | – | 188 |
|
|
2024
Q4 | $21.2K | Sell |
17,575
-5,000
| -22% | -$6.04K | 0.01% | 185 |
|
|
2024
Q3 | $26.9K | Sell |
22,575
-500
| -2% | -$595 | 0.01% | 191 |
|
|
2024
Q2 | $32.3K | Hold |
23,075
| – | – | 0.01% | 184 |
|
|
2024
Q1 | $54.9K | Hold |
23,075
| – | – | 0.01% | 195 |
|
|
2023
Q4 | $85.1K | Sell |
23,075
-4,000
| -15% | -$14.8K | 0.02% | 185 |
|
|
2023
Q3 | $83.7K | Hold |
27,075
| – | – | 0.02% | 183 |
|
|
2023
Q2 | $55.8K | Hold |
27,075
| – | – | 0.01% | 188 |
|
|
2023
Q1 | $60.6K | Buy |
27,075
+5,700
| +27% | +$12.8K | 0.02% | 186 |
|
|
2022
Q4 | $50.2K | Sell |
21,375
-2,100
| -9% | -$4.94K | 0.01% | 179 |
|
|
2022
Q3 | $75K | Sell |
23,475
-16,500
| -41% | -$52.7K | 0.02% | 169 |
|
|
2022
Q2 | $178K | Sell |
39,975
-12,400
| -24% | -$55.2K | 0.05% | 173 |
|
|
2022
Q1 | $272K | Buy |
52,375
+1,000
| +2% | +$5.19K | 0.07% | 167 |
|
|
2021
Q4 | $571K | Sell |
51,375
-100
| -0.2% | -$1.11K | 0.13% | 122 |
|
|
2021
Q3 | $810K | Buy |
51,475
+8,200
| +19% | +$129K | 0.21% | 106 |
|
|
2021
Q2 | $726K | Buy |
+43,275
| New | +$726K | 0.19% | 111 |
|